News | October 15, 2008

Oncology Patients Gain Access to National Clinical Trials

October 16, 2008 - The Radiation Therapy Oncology Group (RTOG) and US Oncology Inc. have entered into a collaboration to increase patient access to national cancer clinical trials with a radiation focus in the community setting.

The collaboration means patients receiving cancer care at practices affiliated with US Oncology have access to RTOG trials for disease sites including brain, head and neck, lung, gastrointestinal, genitourinary, cervix and breast cancers. RTOG trials focus on testing the integration of radiation therapy with new systemic therapies and surgery.

The collaboration also marks the first time US Oncology, as a network of member practices, has participated in cooperative group trials in radiation oncology. In addition, US Oncology is the first multistate, national organization to become an affiliate member of RTOG. Current members include large regional practices and academic practices with several facilities in metropolitan areas.

“Our collaboration with US Oncology and its network of member practices is attractive due to the organization’s strong commitment to clinical trial participation, leadership and accrual,” said Walter Curran, M.D., Group Chairman of RTOG and professor and chairman of the Department of Radiation Oncology of Emory University School of Medicine. Dr. Curran also serves as Chief Medical Officer of the Winship Cancer Center at Emory University. “We were confident their track record as a multisite organization with significant accruals in a variety of clinical trials would be a good fit,” said Dr. Curran.

US Oncology was granted affiliate member status in the RTOG late last year. The collaboration began with 10 US Oncology affiliated practices working as a network, which include: Texas Oncology practices at Sugar Land, Medical City Dallas, Sherman, Methodist Dallas, Klabzuba and Bedford Harris; Kansas City Cancer Center’s North, South and Southwest sites; Willamette Valley (OR) Cancer Center; Central Indian Cancer Center-South; Arizona Oncology Associates-Tucson; Rocky Mountain Cancer Center-Aurora, and New York Oncology Hematology-Albany.

Benefits for patients participating in the radiation therapy trials include increased access to new investigational therapies, the state-of-the-art in standard care and close monitoring by physicians and other clinicians during the trial.

The collaboration provides RTOG access to US Oncology’s large patient population, making radiation therapy trials more accessible to cancer patients in the community setting nationwide.

US Oncology affiliated practices participating in the RTOG trials program have increased access to new investigational radiation therapy treatments and the ability to work with other oncologists and leading researchers to advance the quality of care for cancer patients.

For more information: www.usoncology.com, www.acr.org and www.rtog.org

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init